CG Oncology (CGON) Other Gross PP&E Adjustments (2023 - 2025)

CG Oncology filings provide 3 years of Other Gross PP&E Adjustments readings, the most recent being $8.2 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 5827.54% to $8.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.2 million, a 5827.54% increase, with the full-year FY2025 number at $8.2 million, up 5827.54% from a year prior.
  • Other Gross PP&E Adjustments hit $8.2 million in Q4 2025 for CG Oncology, down from $11.7 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $11.7 million in Q3 2025 to a low of -$1.0 million in Q1 2025.
  • Median Other Gross PP&E Adjustments over the past 3 years was -$329000.0 (2024), compared with a mean of $1.8 million.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 5827.54% in 2025, down 193.31% in 2025.
  • CG Oncology's Other Gross PP&E Adjustments stood at -$422000.0 in 2023, then soared by 132.7% to $138000.0 in 2024, then soared by 5827.54% to $8.2 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $8.2 million (Q4 2025), $11.7 million (Q3 2025), and -$965000.0 (Q2 2025) per Business Quant data.